| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/02/2004 | US20040242470 Molecules secreted by cells and which are capable of inhibiting proliferation of those and/or other cells; for prophylaxis and therapy of proliferative disorders, including, atherosclerosis and cancer |
| 12/02/2004 | US20040242468 For therapy of arthritis |
| 12/02/2004 | US20040242464 Blood substitute for human/mammal transfusions in vivo; comprises lysis/centrifugation of erythrocytes; cross-linking |
| 12/02/2004 | US20040242462 Detecting that individual's Tob gene, transcript and/or protein and comparing with normal Tob gene, transcript and/or protein, differences present indicating that the probability of that individual suffering from amnesia |
| 12/02/2004 | US20040242458 VP1 of foot-and-mouth disease virus |
| 12/02/2004 | US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution |
| 12/02/2004 | US20040241849 Nutrient broth for in propagation, transformation and expression of exogenous gene in bacteria |
| 12/02/2004 | US20040241845 Mammalian staufen and use thereof |
| 12/02/2004 | US20040241826 Mycobacterial antigens expressed during latency |
| 12/02/2004 | US20040241821 Replication competent yellow fever virus for propagation of immunoglobulin conjugate for use in detection tumor associated antigen expression and treatment of cell proliferative disorders in mammals; cancer diagnosis; immunotherapy |
| 12/02/2004 | US20040241807 Interleukin-1 related gene and protein |
| 12/02/2004 | US20040241806 G-CSF polypeptides and conjugates |
| 12/02/2004 | US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders |
| 12/02/2004 | US20040241804 Novel polypeptide, a cDNA encoding the same, and use of it |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241802 Adiponectin receptor and gene encoding the same |
| 12/02/2004 | US20040241801 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 12/02/2004 | US20040241800 Vascular endothelial growth factor dimers |
| 12/02/2004 | US20040241797 Use of alphacp1, alphacp2, and hur for modulating gene expression and inducing angiogenesis |
| 12/02/2004 | US20040241792 Substrates and assays for beta-secretase |
| 12/02/2004 | US20040241778 Novel polypeptide |
| 12/02/2004 | US20040241775 Methods and kits for determining risk of pre-term delivery |
| 12/02/2004 | US20040241761 Using human estrogen receptor gene expression as diagnostic indicator of diabetes; antidiabetic agents |
| 12/02/2004 | US20040241758 CD 30 ligand |
| 12/02/2004 | US20040241757 Membrane protein for use in identifying modulators for treatment and prevention neuronal trauma and disorders |
| 12/02/2004 | US20040241737 Methods for diagnosing mood disorders |
| 12/02/2004 | US20040241731 Methods of producing nucleic acid ligands |
| 12/02/2004 | US20040241720 Sodium activated potassium ion channel for therapeutic drug screening |
| 12/02/2004 | US20040241715 Genes identified as required for proliferation in escherichia coli |
| 12/02/2004 | US20040241710 Methods of detecting colorectal cancer |
| 12/02/2004 | US20040241702 Expression vector comprising nucleotide sequences coding novel gene which is expressed in prostate tissues for use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; immunotherapy |
| 12/02/2004 | US20040241695 Hemocyanin nucleic acids and polypeptides and related vectors fusion protein conjugates cells and methods of use |
| 12/02/2004 | US20040241694 Using expression patter of neurodegenerative marker to diagnose/prognose brain disorders |
| 12/02/2004 | US20040241689 Using immunoglobulins to bind cell surface receptor and prevent microbial infection; bactericides; immunotherapy; transport protein inhibition |
| 12/02/2004 | US20040241687 Bacterial polypeptide for use in developing genetic vaccine for prevention and treatment of respiratory system disorders |
| 12/02/2004 | US20040241686 Vector comprising nucleotide sequences coding oncogenic protein for use in identication of modulators for treatment and prevention of cell proliferative and metabolic disorders |
| 12/02/2004 | US20040241683 Hsst and angiogenesis |
| 12/02/2004 | US20040241673 Non-cytotoxic pap mutants |
| 12/02/2004 | US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines |
| 12/02/2004 | US20040241657 Nucleotide sequences which hybridizes to variant/allelic sequence in haplotype block for use in diagnosis and prognosis of hepatic and inflammatory disorders |
| 12/02/2004 | US20040241652 Vector comprising nucleotide sequences coding fusion protein for use in identifying modulators to treat and prevent infection and cell proliferative disorders |
| 12/02/2004 | US20040241651 Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations |
| 12/02/2004 | US20040241642 Polynucleotide fragments of an infections human endogenous retrovirus |
| 12/02/2004 | US20040241641 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
| 12/02/2004 | US20040241640 Internalisation of virus into cells |
| 12/02/2004 | US20040241639 Human tachykinin-related splice variants and compositions thereof |
| 12/02/2004 | US20040241638 Bacterial polypeptide for use in developing genetic vaccine for prevention and treatment of respiratory system disorders |
| 12/02/2004 | US20040241248 Crosslinking the carboxylic acid groups in a glycosaiminoglycan with a primary amine in a lipid to form particles that can be used to encapsulate various drugs, especially chemotherapeutic agents |
| 12/02/2004 | US20040241191 Recombinant vaccine against West Nile virus |
| 12/02/2004 | US20040241187 An inactivated, disrupted influenza virus preparation of a hemagglutinin antigen stabilised by alpha-tocopherol succinate in the absence of thiomersal or at low levels of thiomersal; hemagglutinin detectable by a single radial immunoassay (SRID); mercury-free preservative; administering by any route |
| 12/02/2004 | US20040241182 lymphocytes; immunogens; fusion proteins; for treatment/prevention of infection |
| 12/02/2004 | US20040241181 Preferentially inducing a more potent CD8+ T cell response to an immunogen by delivering a recombinant simian adenovirus comprising a nucleic acid molecule encoding an immunogen under the control of gene expression regulatory sequences directing expression of the immunogen; HIV; rabies; papilloma virus |
| 12/02/2004 | US20040241180 Notch |
| 12/02/2004 | US20040241178 Allergen peptide fragments and use thereof |
| 12/02/2004 | US20040241177 Novel compositions and uses therefor |
| 12/02/2004 | US20040241171 Leukocyte inactivation module |
| 12/02/2004 | US20040241168 Compositions and methods for the treatment and clinical remission of psoriasis |
| 12/02/2004 | US20040241166 Use of inhibitors of ikk-beta and method for discovery of said inhibitors |
| 12/02/2004 | US20040241165 RFamide-Related Peptide-3 (RFRP-3); orphan g protein coupled receptors; for promoting prolactin secretion; treating hypoovarianism, seminal vesicle hypoplasia, menopausal syndrome and hypothyroidism |
| 12/02/2004 | US20040241163 Secreted human cytomegalovirus protein or fragment thereof binds rantes chemokine; for treating chemokine-associated inflammatory or immune pathological conditions such as transplant rejection, arteriosclerosis, rheumatoid arthritis, asthma, endometriosis, and cancer |
| 12/02/2004 | US20040241161 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
| 12/02/2004 | US20040241143 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 12/02/2004 | US20040241141 gene delivery using retroviral genetic vectors such that the gene is expressed at sufficient levels and for a sufficient time for prophylaxis of rheumatic diseases in humans or mammals |
| 12/02/2004 | US20040241140 Expression vectors able to elicit improved immune response and methods of using same |
| 12/02/2004 | US20040241139 viral genes in covalent junction with foreign, genetically engineered genes; ribonucleic acid segments having upstream splicing donors and downstream splicing acceptor signal surrounding the proximal coding regions; vaccines |
| 12/02/2004 | US20040241137 vaccines comprising antigen bearing targets and fusion polypeptide having amino acid sequences which can bind to a carbohydrate and serve as and ligands for cell surface polypeptide of leukocytes |
| 12/02/2004 | US20040241129 Amphiphilic complexes, method for their preparation and compositions containing them |
| 12/02/2004 | US20040241102 Methods of using immunoglobulin (Ig) compositions |
| 12/02/2004 | US20040241095 Complex containing cyanine dyes; supplying to target tumor cells |
| 12/02/2004 | US20040238597 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 12/02/2004 | DE10321963A1 Verfahren zur Herstellung eines Plastid-dirigierten Proteins in Pflanzenzellen A method for producing a plastid-directed protein into plant cells |
| 12/02/2004 | DE10319073A1 Importin-α mit inaktivierter autoinhibitorischer Domäne zur Diagnose Importin-α with inactivated autoinhibitorischer domain for diagnosis |
| 12/02/2004 | CA2690035A1 Use of a mouse to screen for an inhibitor of interleukin 18 production in keratinocytes |
| 12/02/2004 | CA2526790A1 Method for screening inhibitors of the gamma-secretase |
| 12/02/2004 | CA2526697A1 Use of a polypeptide |
| 12/02/2004 | CA2526675A1 Crystalline vap-1 and uses thereof |
| 12/02/2004 | CA2526654A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease |
| 12/02/2004 | CA2526582A1 Chondroitin ac lyase crystal |
| 12/02/2004 | CA2526579A1 Methods for protein labeling based on acyl carrier protein |
| 12/02/2004 | CA2526493A1 Means for preventing and treating cellular death and their biological applications |
| 12/02/2004 | CA2526440A1 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 12/02/2004 | CA2526403A1 New enterovirus, vaccines, medicaments and diagnostic kits |
| 12/02/2004 | CA2526275A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them |
| 12/02/2004 | CA2526069A1 Modified antiviral peptides with increased activity and cell membrane affinity |
| 12/02/2004 | CA2525831A1 Process for manufacture of nematode-extracted anticoagulant protein (nap) |
| 12/02/2004 | CA2525698A1 A nucleic acid construct containing a nucleic acid derived from the genome of hepatitis c virus (hcv) of genotype 2a, and a cell having such nucleic acid construct introduced therein |
| 12/02/2004 | CA2525696A1 Control of function of intracellular ca ion |
| 12/02/2004 | CA2525574A1 Stable analogs of peptide and polypeptide therapeutics |
| 12/02/2004 | CA2525181A1 Tnf-like secreted protein |
| 12/02/2004 | CA2524936A1 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 12/02/2004 | CA2524860A1 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 12/02/2004 | CA2524707A1 Repeat sequence protein polymer active agent conjugates, methods and uses |
| 12/02/2004 | CA2524693A1 Metal chelate complexes immobilized on solid supports for peptide preparation |
| 12/02/2004 | CA2524130A1 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 12/02/2004 | CA2469528A1 Peptide and peptide mimetic derivatives having integrin inhibitor properties iii |
| 12/02/2004 | CA2429891A1 Membrane fusion protein |
| 12/01/2004 | EP1482052A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype B |
| 12/01/2004 | EP1482046A2 G-CSF analog compositions and methods |
| 12/01/2004 | EP1482045A2 G-CSF analog compositions and methods |
| 12/01/2004 | EP1482044A2 Multivariant IL-3 hematopoiesis fusion protein |